Transdermal Delivery of Treatment for Alzheimer's Disease: Development, Clinical Performance and Future Prospects

Author： Chan Agnes L.F.   Chien Yie W.   Shun Jin Lin  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.9, 2008-01, pp. : 761-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microemulsion-based patch for transdermal delivery of huperzine A and ligustrazine phosphate in treatment of Alzheimer’s disease

By Shi Jun   Cong Wenjuan   Wang Yiming   Liu Qingfei   Luo Guoan  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 6, 2012-06 ,pp. : 752-761

Informa Healthcare

Access to resources Recommend Favorite

Dermal and Transdermal Drug Delivery Systems: Current and Future Prospects

By Brown Marc   Martin Gary   Jones Stuart   Akomeah Franklin  

Drug Delivery, Vol. 13, Iss. 3, 2006-05 ,pp. : 175-187

Informa Healthcare

Access to resources Recommend Favorite

Dietary Polyphenols for Treatment of Alzheimer’s Disease– Future Research and Development

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 4, 2014-04 ,pp. : 330-342

Bentham Science Publishers

Access to resources Recommend Favorite

Future directions in the treatment of Alzheimer’s disease

By Bullock Roger  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 303-314

Informa Healthcare

Access to resources Recommend Favorite

Drugs in Clinical Development for Alzheimer's Disease: Summary and Table†

By  

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 73-79

Adis International

Access to resources Recommend Favorite